Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II–III resectable rectal cancer: 5-Year survival data of a randomized controlled trial
Background and objective: At present, there are common recommendations for treatment for stage II–III resectable rectal cancer patients: preoperative conventional chemoradiotherapy (CRT) with delayed surgery in 6–8 weeks or preoperative short-course radiotherapy (SCRT) followed by immediate surgery....
Main Authors: | Laura Kairevičė, Tadas Latkauskas, Algimantas Tamelis, Aleksandras Petrauskas, Henrikas Paužas, Tadas Žvirblis, Laimonas Jaruševičius, Žilvinas Saladžinskas, Dainius Pavalkis, Rasa Jančiauskienė |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-01-01
|
Series: | Medicina |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1010660X17300460 |
Similar Items
-
The Role of <i>VEGFA, COX2, HUR </i>and <i>CUGBP2</i> in Predicting the Response to Neoadjuvant Therapy in Rectal Cancer Patients
by: Henrikas Pauzas, et al.
Published: (2020-04-01) -
Post-chemoradiotherapy adjuvant chemotherapy of rectal cancer
by: E. V. Ledin, et al.
Published: (2018-08-01) -
ADJUVANT CHEMOTHERAPY AFTER RECTAL CANCER CHEMORADIOTHERAPY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01) -
Adjuvant chemotherapy: an autoethnography
by: Greenhalgh, T
Published: (2017) -
Adjuvant chemotherapy for colorectal cancer.
by: Kerr, D, et al.
Published: (1996)